CDC Website CDC Website

To Join the NPIN community or

Home » Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)

Due to the evolving COVID-19 situation, NPIN may not have the most up-to-date organization changes to services or hours. Please call the organization or visit their website to find out about any changes. This site does not have information about where to get tested for COVID-19. For COVID-19 information please visit: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

Debido a la rápida evolución de la situación con respecto al COVID-19, NPIN podría no tener la información mas actualizada de los servicios u horas de las organizaciones. Por favor llame o visite la página web de la organización para conocer los cambios. Este sitio no tiene información sobre donde hacerse la prueba del COVID-19. Para información sobre el COVID-19 por favor visite: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)

The purpose of this funding announcement is to support preclinical HIV/AIDS research using NHP models performed by Early Stage Investigators who are within 10 years of their terminal degree or residency training but who have at least two years of postdoctoral experience. The goal of this support is to help advance HIV/AIDS researchers using NHP models in preclinical research by providing a degree of independence for these Early Stage Investigators to develop new research directions and to position these researchers to be competitive for new research project (e.g., R01) funding. Research must be in the field of HIV/AIDS translational studies, using NHPs as preclinical models. This funding initiative encompasses all objectives of the fiscal year (FY) 2019/2020 NIH strategic plan for HIV and HIV-Related Research (https://www.oar.nih.gov/hiv-policy-and-research/strategic-plan), including research directed towards prevention and cure of HIV infection; next-generation therapies; understanding the roles of comorbidities, coinfections and complications; and cross-cutting activities such as building capacity.

Application Due Date
9/7/20
Project Start Date
4/1/21
Application Contact
Stephanie
Blackford
Grants Management Contact
301-827-7536
stephanie.blackford@nih.gov
Technical Contact
Sige
Zou, PhD
Health Scientist Administrator
sige.zou@nih.gov
301-435-0749
Fund Duration
The total project period may not exceed 2 years.
Subjects
Audiences

Fund Number: 

346942

Fund ID: 

PAR-20-212

Last modified: 

6/17/20